Nitroalkene derivatives of linoleic acid (nitrolinoleic acid, LNO 2 ) and oleic acid (OA-NO 2 ) are endogenous lipid products with potent anti-inflammatory properties. The present study was undertaken to evaluate the therapeutic potential of OA-NO 2 a mouse model of renal ischemia/reperfusion (I/R) injury. B6129SF2/J mice were subjected to bilateral renal ischemia for 30-min, followed by 24 h of reperfusion. 50 min after ischemia, mice received intraperitoneal (IP) injections of OA-NO 2 (500 µg/kg; I/R OA-NO 2 ), vehicle for OA-NO 2 (i.e., 0.8 ml/kg ethanol; I/R veh), or oleic acid (500 µg/kg; I/R OA) every 6 h during the 24 h recovery period. A sham-operated group was not subjected to ischemia and received 0.8 ml/kg ethanol IP every 6 h during the 24 h recovery period (sham veh). While plasma urea and creatinine were elevated (p<0.05) in I/R veh vs. sham veh mice, the severity was less (p<0.05) in I/R OA-NO 2 animals. Indices of histological damage, polymorphonucleocyte infiltration, together with expression of intracellular adhesion molecule-1, interleukin-1β, and tumor necrosis factor-α, p47 phox and gp91 phox were greater in I/R veh vs. sham veh mice, but were attenuated (p<0.05) in I/R OA-NO 2 animals. Because indices of renal dysfunction were similar between I/R veh and I/R OA mice (p>0.05), but less (p<0.05) in I/R OA-NO 2 animals compared to both groups, protection from bilateral renal ischemia is afforded by the nitrated but not free form of oleic acid.
Introduction
Renal ischemia and reperfusion (I/R) injury is a common cause of acute renal failure (ARF) in patients (1, 7) . In ischemic ARF there is reduced renal blood flow, an impaired ultrafiltration coefficient, and tubular obstruction (16, 43) . These events result in tissue hypoxia and subsequently trigger pathophysiological processes that include polymorphonucleocyte (PMN) infiltration into the kidney, together with activation of pro-inflammatory cytokines, reactive nitrogen species, reactive oxygen species (ROS), and the coagulation system (2, 42) . If the intensity and/or duration of ischemia are sufficient, these processes can lead to cell death and compromise renal function (6, 39, 44) . Although mechanisms responsible for renal I/R injury in experimental animal models have been investigated extensively, pharmacological interventions designed to target a specific factor in this process have not been efficacious in the clinical setting (1) . Despite the advances in critical care medicine, the high mortality and morbidity rate from ARF has remained unchanged over the past 50 years (5, 9, 41) . Thus, a need exists to identify new intervention strategies.
Recently, nitrated free fatty acids (NO 2 -FA), notably nitroalkene derivatives of linoleic acid (nitrolinoleic acid, LNO 2 ) and oleic acid (OA-NO 2 ) are found to be endogenous molecules with several attractive signaling properties (4, 38) . These derivatives are formed via nitric oxide (NO)-dependent oxidative reactions (31, 36, 37) . Plasma concentrations are ~0.5 µM for LNO 2 (4) and ~0.6 µM for OA-NO 2 (4) in healthy human blood and combined blood levels of these two fatty acid derivatives exceed 1 µM, indicating their capability to act in physiological concentration ranges. Nitroalkenes display potent anti-inflammatory properties as they inhibit human neutrophil superoxide generation, degranulation, and integrin expression (8) , and also attenuate lipopolysaccharide-induced secretion of pro-inflammatory cytokines in cultured macrophages (10) . Additionally, nitroalkenes are found to be a robust endogenous ligand for peroxisome proliferator-activated receptor γ (PPARγ) although they also activate PPARα and PPARδ at increasing concentrations (4, 38) . PPARs have emerged as a novel therapeutic target for treatment of metabolic syndrome as well as other inflammatory diseases such as ischemic ARF (17) . Finally, nitroalkenes exhibit other signaling properties, such as releasing nitric oxide (28). However, to date, there are no prior studies to examine their biological function in vivo.
Herein, the present study examines the therapeutic potential of OA-NO 2 in a mouse model of renal I/R injury generated by 30 min of bilateral ischemia followed by 24 h reperfusion.
Methods

Materials.
9-Nitro-oleic acid and 10-nitro-oleic acid are two regioisomers of nitro-oleic acid (OA-NO 2 ), which are formed by nitration of oleic acid (OA) in approximately equal proportions in vivo (4). The two compounds were purchased from Cayman Chemicals (Ann Arbor, MI) (9-nitro-oleic acid: Cat#10008042; 10-nitro-oleic acid: Cat#10008043), dissolved in ethanol, and used as an 1:1 mixture of the isomers. OA was purchased from the same company (Cat#: 90260) and dissolved in the same solvent. All other reagents were purchased from Sigma-Aldrich unless otherwise specified.
Animals and treatment groups.. All protocols were approved by the Institutional Animal Care and Use Committee of the University of Utah. Three-month old male B6129SF2/J mice were maintained in a temperature-controlled barrier facility with a 12-hour light/dark cycle and were given free access to standard laboratory chow and tap water. Animals were anesthetized initially with 2-5% isoflurane, placed on a heated surgery table, and maintained on 2% isoflurane while breathing spontaneously. After making a 1 cm incision in the abdomen, the left and right renal arteries were located, isolated, and occluded for 30-min using microaneurysm clips to produce ischemia. After removing the clips, verifying reperfusion, and closing the incision in two layers, anesthesia was terminated and 1 ml of 37°C saline was injected into the abdomen to supplement fluid loss. 1 h after the commencement of ischemia, the animals were randomly divided to receive intraperitoneal (IP) injections of OA-NO 2 (500 µg/kg), vehicle for OA-NO 2 (i.e., 0.8 ml/kg ethanol), or oleic acid (500 µg/kg) every 6 h. A sham-operated group underwent identical surgical procedures except that microaneurysm clamps were not applied; these mice received 0.8 ml/kg ethanol IP every 6 h. In a separate experiment, the I/R animals received a single injection of OA-NO 2 (2.0 mg/kg) or ethanol (0.8 ml/kg). After 24 h mice were anesthetized using 2%
isoflurane, 500-600 µl of blood was obtained from the inferior vena cava, and both kidneys were excised.
Measurement of myeloperoxidase. Myeloperoxidase (MPO) was measured in one kidney as an indicator of PMN infiltration. Immediately upon excision the kidney was weighed, homogenized in 10 mmol/L potassium phosphate buffer containing 0.5% hexadecyltrimethylammonium bromide, centrifuged for 15 minutes at 1500 g at 4° C, and the supernatant used to assess MPO activity (ng/100 mg wet weight) using spectrophotometric techniques according to the manufacturers guidelines (Hycult Biotechnology, Uden, the Netherlands).
Measurement of circulating TNF-α. Circulating TNF-α was measured by using a commercially available enzyme immunoassay kit (BD Biosciences, San Jose, CA) according to the manufacturers' instructions.
Measurement of biochemical parameters. Blood samples from anesthetized mice were obtained after renal ischemia/reperfusion for 24 hours. Plasma levels of urea and creatinine were measured using standard urease assay/conductivity and picric acid reactions, respectively.
Morphological studies. Kidneys were hemi-sectioned and fixed by direct immersion in 3% paraformaldehyde for 16 hours. Following embedding in paraffin, 4 µm sections were prepared and stained with hematoxylin and eosin and analyzed with light microscope. Renal pathology scores were generated by an observer who was blind as to the identity of the specimen. The following parameters were scored on a 1-3 scale as described elsewhere (40 Immunoblotting.
The lysates of the kidney were stored at -80°C until assayed. Protein concentrations were determined using Coomassie reagent. An equal amount of the whole tissue protein (60 μg) was denatured at 100℃ for 10 min, separated by SDS-PAGE, and transferred onto nitrocellulose membranes. The blots were blocked overnight with 5% nonfat dry milk in Tris-buffered saline (TBS),
followed by incubation for 1 h with rabbit polyclonal antibody against IL-1ß (Cat#: sc-7884, Santa Cruz Biotechnology, Santa Cruz, CA), mouse monoclonal antibody against TNF-α (Cat#: sc57469, Santa
Cruz Biotechnology, Santa Cruz, CA), or mouse monoclonal antibody against α-tubulin (Cat#: T5168, Sigma, St. Louis, MO). The blots were washed with TBS followed by incubation with goat anti-rabbit or anti-mouse HRP-conjugated secondary antibody. Immune complexes were detected using ECL methods. The immunoreactive bands were quantified using the Gel and Graph Digitizing System (Silk Scientific Corporation, Tustin, CA).
Measurement of thiobarbituric acid-reactive substances (TBARS). The measurement of TBARS
in the mouse kidney was based on the formation of malondialdehyde (MDA) by using a commercially available TBARS Assay kit (Cat#: 10009055, Cayman Chemical, Ann Arbor, MI)
according to the manufacturers' instructions.
Statistical analysis.
Values shown represent means ± S.E. Data were analyzed using one-way ANOVA followed by a Bonferroni posttest. P value <0.05 was considered significant.
Results
Renal injury. After 24 h of reperfusion plasma urea and creatinine were 5.6-fold and 9. Fig. 2A) . These mice had a significantly reduced semiquantitative histological damage score in the renal cortex as compared to I/R veh mice (Fig. 2B ).
These data indicate that functional and histological indices of renal I/R injury were attenuated by OA-NO 2 treatment during the 24-h reperfusion period.
Renal MPO levels. MPO is a predominant enzyme in the monocytes and in the azurophilic granules of PMN and is released upon neutrophil activation. This enzyme has been shown to play a detrimental role in the induction of renal I/R injury (30) . Therefore, we determined tissue MPO levels using ELISA. Renal MPO levels were 4.6-fold greater in I/R veh vs. sham veh mice (Fig. 3) . Strikingly, the increase in renal MPO was almost completely abolished in I/R OA-NO 2 mice, demonstrating the ability of OA-NO 2 treatment during reperfusion to attenuate I/Rinduced PMN infiltration (Fig. 3) . Renal oxidative stress. Renal p47 phox and gp91 phox were 24.5-fold and 2.0-fold greater, respectively, in I/R veh vs. sham veh mice (Fig. 6 ). While the increase in p47 phox (15.5-fold) and gp91 phox (1.2-fold) was greater in I/R OA-NO 2 vs. sham veh mice, it was less severe compared to I/R veh animals (Fig. 6 ). The levels of kidney TBARS, an index of lipid peroxidation, were significantly elevated in I/R veh vs. sham veh mice and were almost completely normalized in I/R OA-NO 2 mice (Fig. 6 ). These data suggest that OA-NO 2 lessened NADPH oxidase subunit activation and ROS generation in response to I/R.
Expression of pro-inflammatory cytokines
Effect of a single injection of OA-NO 2 . Of note, the above discussed data were all obtained with multiple i.p. injections of OA-NO 2 (500 µg/kg, every 6 h). We also examined the effect of a were activated to a greater degree in I/R vs. sham-operated mice. Finally, indices of oxidative stress, including the expression of p47 phox and gp91 phox , the key subunits of NADPH oxidase, and the levels of TBARS, were elevated in response to I/R. Collectively, these data indicate our I/R protocol evoked significant renal injury. To test whether OA-NO 2 ameliorates indices of renal I/R injury we administered this compound at 1 h of ischemia, and every 6 h for 24 h thereafter.
Plasma urea and creatinine, renal tubular damage, MPO activity, pro-inflammatory cytokines, and p47 phox and gp91 phox gene expression were less in I/R OA-NO 2 vs. I/R vehicle mice. As such, functional and histological damage, PMN infiltration, inflammation, and indices of oxidant stress, respectively, were attenuated by the nitrated fatty acid OA-NO 2 .
Inflammation has been recognized as a critical factor in the development and progression of IR injury. Specifically, inflammation is an important mechanism to initiate and maintain renal cell injury as it potentates both necrosis (26, 27) and apoptosis (11) (12) (13) . Early in the 1980s,
Romson and co-workers observed that neutrophil depletion reduced myocardial injury resulting from temporary artery occlusion (34) . Similarly, prevention of PMN adherence using a monoclonal antibody against the ß-chain of the CD18 complex significantly attenuated I/Rinduced microvascular permeability in intestines (19) . Neutrophil invading damaged tissues constitutes to the local inflammatory response in part by releasing their lysosomal constitutes including MPO. MPO, a 140-kDa protein present in the cytoplasm of neutrophils, represents one of the most abundant enzymes released on neutrophil activation (21) . Renal I/R injury is associated with neutrophil infiltration (18) and increased tissue MPO activity (29, 32) . A definitive role of MPO in renal IR injury is recently demonstrated using MPO knockout mice (Mpo -/-) (30) . These mice exhibited improved renal function after I/R when compared with their WT controls. Interestingly, MPO release by the activated neutrophils is important for the activation and adherence of other neutrophils (20, 22) . In line with this notion, the neutrophil accumulation was significantly reduced in Mpo -/-mice (30) . As expected, we found that I/R veh mice had a marked increase in renal MPO levels as compared with sham controls. Strikingly, the rise of MPO after I/R was almost completely blocked by delayed administration of OA-NO 2 ,
suggesting that inhibition of neutrophil activation may represent a primary mechanism for the renoprotective action of the nitrated lipid. Indeed, there is in vitro evidence that LNO 2 inhibited phorbol 12-myristate 13-acetate or N-formyl-Met-Leu-Phe-evoked neutrophil activation as assessed by measurements of superoxide generation, Ca 2+ influx, elastase release, and CD11b
expression (8).
A major superoxide generating system in the activated neutrophils is NADPH oxidase that is comprised of membrane associated subunits, p22 phox , gp91 phox , and cytosolic subunits, p47 phox , p67 phox , and p40 phox . Among these subunits, gp91 phox and p47 phox are of particular importance as the former contains the catalytic domain and the later is necessary for cytosolic subunit translocation and for initiation of NADPH oxidase assembly (3, 14, 15) . We found that OA-NO 2 was effective in reducing I/R-induced expression of both gp91 phox and p47 phox .
Considering that the activated neutrophils may constitute a major source of ROS production during I/R, it seems reasonable to speculate that the reduction of NADPH oxidase expression by OA-NO 2 might be the result of reduced neutrophil infiltration. It is also possible that OA-NO 2 may exert a direct inhibitory effect on gene expression of NADPH oxidase. Of note, OA-NO 2 treatment produced a nearly complete blockade of I/R-induced increases in renal TBARS, which can not be fully explained by the partial effect on NADPH oxidase expression. Therefore, it seems reasonable to speculate that other sources than NADPH oxidase may also contribute to I/R-induced ROS generation and may serve as an additional target of OA-NO 2 .
In the present study, the anti-inflammatory properties of OA-NO 2 in the mouse model of renal I/R injury was also evidenced by the amelioration of the production of pro-inflammatory cytokines (i.e. TNF-α and IL-1ß) and adhesion molecules (i.e. ICAM1) which may involve not only neutrophils but also other inflammatory cells such as macrophages and lymphocytes. We found that OA-NO 2 significantly reduced I/R-induced increases in renal IL-1ß, and ICAM1 expression and circulating TNF-α. In general, these findings agree with the observation that LNO 2 and OA-NO 2 exerted a direct inhibitory effect on secretion of various pro-inflammatory cytokines as well as the NF-kB activation in RAW264.7 macrophages exposed to lipopolysaccharide (10) . 
